Skip to content
10-Q

Quarterly Report

Avant Diagnostics, Inc

0001493152-18-014807

← back to feed
Filed
Oct 23, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · Aug 29, 2018 336.96M sh
Stockholders Equity Q1 2017 · Dec 31, 2016 $2.13M
Stockholders Equity Q1 2017 · Sep 30, 2016 $3.56M
Current Liabilities Q1 2017 · Dec 31, 2016 $3.88M
Current Liabilities Q1 2017 · Sep 30, 2016 $2.12M
Total Liabilities Q1 2017 · Dec 31, 2016 $3.88M
Total Liabilities Q1 2017 · Sep 30, 2016 $2.12M
Current Assets Q1 2017 · Dec 31, 2016 $246.02K
Current Assets Q1 2017 · Sep 30, 2016 $42.23K
Total Assets Q1 2017 · Dec 31, 2016 $6.01M
Total Assets Q1 2017 · Sep 30, 2016 $5.68M
Operating Cash Flow Q1 2017 · Dec 31, 2015 −$18.19K
Cash And Equivalents Q1 2017 · Dec 31, 2015 $112.77K
Cash And Equivalents Q1 2017 · Sep 30, 2015 $43.64K
Sga Expense restated Q1 2017 · Dec 31, 2015 $120.39K
Net Income Q1 2017 · Dec 31, 2015 −$197.54K
Operating Income Q1 2017 · Dec 31, 2015 −$197.54K